The safety profile was consistent with GLP-1 receptor agonists, with gastrointestinal events including nausea, vomiting, diarrhea, constipation, or abdominal pain, being most common (affecting 79.6% in the cagrilintidesemaglutide group and 39.9% in the placebo group) but mainly transient and mild to moderate in severity
P., Stylianopoulos, T., Boucher, Y., & Jain, R
Shao, J
NKG2D The regulation of the immune system activity by senescent cells is a key factor by which age-related diseases are developing in the human body
Small-molecule drugs including monocrotaline, doxorubicin, rifampicin, and phenytoin increased cell engraftment versus controls by causing hepatic endothelial damage (Wu et al., 2008)
"Why does my head spin when I'm drunk?"